320
Participants
Start Date
June 30, 2012
Primary Completion Date
June 30, 2021
Study Completion Date
June 30, 2021
chemotherapy ± targeted therapy
Chemotherapy regimen with either mFOLFOX6 plus cetuximab, bevacizumab or mFOLFOX6 alone were allocated, according the RAS genotype and patient affordability.
Zhongshan hospital, Fudan university, Shanghai
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Ruijin Hospital
OTHER
Changhai Hospital
OTHER
Fudan University
OTHER